跳至主要内容
临床试验/CTRI/2023/11/060280
CTRI/2023/11/060280尚未招募2 期

Effectiveness of Individualized Homoeopathic Medicines in LM Potencies in the management of children with Autism Spectrum Disorder

Dr Sourabh Balgonda Patil1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年12月4日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
Assessment of reduction in the severity of symptoms in children with Autism Spectrum Disorder after the administration of Individualized Homoeopathic Medicines in LM potencies is planned to be done every month using the Indian Scale for Assessment of Autism (ISAA).

研究概览

简要总结

This study is an open label, single arm, clinical interventional study to determine the effectiveness of Individualized Homoeopathic Medicines in LM potencies in the management of children with Autism Spectrum Disorder that will be conducted in OPD, IPD and Peripheral units of Department of Psychiatry at National Homoeopathy Research Institute in Mental Health, Kottayam. The primary outcome measures will be, the reduction in the severity of symptoms; assessed using the Indian Scale for Assessment of Autism (ISAA) every monthly. The secondary outcome will be, the changes in the challenging behavior; assessed every three months by using the Aberrant Behavior Checklist (ABC) scale. As the study with the aforementioned domains is one of its kind, it aims to make the efforts to offer possibilities for future research in the effectiveness of Individualized Homoeopathic Medicines in LM potency in management of children with Autism Spectrum Disorder in general and in the management of challenging behaviors in particular.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 17.00 Year(s)(—)
性别
All

入选标准

  • Children in the age group of 3 to 17 years and both sexes.
  • Participants diagnosed with Autism Spectrum Disorder as per the DSM–V.

排除标准

  • Participants diagnosed with any organic disorders.
  • Participants with any other serious medical illness and multiple disabilities.

结局指标

主要结局

Assessment of reduction in the severity of symptoms in children with Autism Spectrum Disorder after the administration of Individualized Homoeopathic Medicines in LM potencies is planned to be done every month using the Indian Scale for Assessment of Autism (ISAA).

时间窗: Every month from baseline till the conclusion of the study (12th month)

次要结局

  • The changes in the challenging behavior in children with Autism Spectrum Disorder after the administration of Individualized Homoeopathic Medicines in LM potencies will be assessed at baseline, at 3rd, 6th, 9th month and at the conclusion of the study by using the Aberrant Behavior Checklist (ABC) scale.(Baseline, at 3rd, 6th, 9th month and at the conclusion of the study (12th month))

研究者

发起方
Dr Sourabh Balgonda Patil
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr. Sourabh Balgonda Patil

National Homoeopathy Research Institute in Mental Health

研究点 (1)

Loading locations...

相似试验